Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
- PMID: 17008692
- DOI: 10.1200/JCO.2005.04.4859
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
Abstract
Purpose: Small-cell lung cancer (SCLC) is a histologic subtype of lung cancer with a distinct biology and clinical course. It has been observed that the incidence of SCLC has been decreasing over the last several years.
Methods: We used the Surveillance, Epidemiologic, and End Results (SEER) database to determine the incidence of SCLC over the last 30 years. In addition, we sought to determine sex- and stage-based differences in the incidence and survival of SCLC among a proportion of reported cases of lung cancer over the last 30 years (1973 to 2002). Joinpoint analyses were applied to test the trends in annual percentage change for statistical significance.
Results: The proportion of SCLC (among all lung cancer histologic types) decreased from 17.26% in 1986 to 12.95% in 2002. Of all patients with SCLC, the proportion of women with SCLC increased from 28% in 1973% to 50% in 2002. A modest but statistically significant improvement in 2- and 5-year survival was noted among both limited-stage SCLC and extensive-stage SCLC cohorts during the study period.
Conclusion: Our analysis indicates that the incidence of SCLC is decreasing in the United States, and only modest improvements have been seen in survival over the last 30 years. Possible explanations for the decreasing incidence include the decrease in the percentage of smokers and the change to low-tar filter cigarettes. Despite trends toward modest improvement in survival, the outcome remains very poor.
Comment in
-
Changing face of small-cell lung cancer: real and artifact.J Clin Oncol. 2006 Oct 1;24(28):4526-7. doi: 10.1200/JCO.2006.07.3841. J Clin Oncol. 2006. PMID: 17008688 No abstract available.
Similar articles
-
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922
-
Contemporary lung cancer trends among U.S. women.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):582-5. doi: 10.1158/1055-9965.EPI-04-0554. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767333
-
Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.J Clin Oncol. 2007 Dec 10;25(35):5570-7. doi: 10.1200/JCO.2007.12.5435. J Clin Oncol. 2007. PMID: 18065729
-
[Is there progress in the chemotherapy of small cell lung cancer?].Schweiz Med Wochenschr. 1999 Sep 18;129(37):1313-20. Schweiz Med Wochenschr. 1999. PMID: 10515004 Review. German.
-
Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Arch Phys Med Rehabil. 2008. PMID: 18373987 Review.
Cited by
-
Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer.Front Oncol. 2021 May 17;11:603271. doi: 10.3389/fonc.2021.603271. eCollection 2021. Front Oncol. 2021. PMID: 34079751 Free PMC article.
-
Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003).Thorac Cancer. 2023 Jan;14(1):105-107. doi: 10.1111/1759-7714.14727. Epub 2022 Nov 15. Thorac Cancer. 2023. PMID: 36380738 Free PMC article.
-
Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation.iScience. 2022 Oct 12;25(11):105338. doi: 10.1016/j.isci.2022.105338. eCollection 2022 Nov 18. iScience. 2022. PMID: 36325065 Free PMC article.
-
Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department.J Thorac Dis. 2015 Feb;7(Suppl 1):S12-9. doi: 10.3978/j.issn.2072-1439.2015.01.57. J Thorac Dis. 2015. PMID: 25774302 Free PMC article.
-
MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.Aging (Albany NY). 2016 Oct 18;8(10):2509-2524. doi: 10.18632/aging.101080. Aging (Albany NY). 2016. Retraction in: Aging (Albany NY). 2024 Aug 31;16(16):12104. doi: 10.18632/aging.205987 PMID: 27777383 Free PMC article. Retracted.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical